Vor Biopharma Inc.
VOR | NASDAQ
$23.06
+$1.17 (+5.34%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 3.49M | 8.96M | n/a | n/a |
Gross Profit | n/a | n/a | -3.49M | -8.96M | n/a | n/a |
Operating Income | -371.64M | -121.19M | -126.04M | -93.42M | -69.02M | -43.37M |
Interest Income | 5.87M | 4.27M | 8.17M | 1.32M | 119K | 29K |
Pretax Income | -695.98M | -116.91M | -117.86M | -92.09M | -68.9M | -43.34M |
Net Income | -695.98M | -116.91M | -117.86M | -92.09M | -68.9M | -43.34M |
Selling & General & Admin | 50.11M | 27.88M | 31.72M | 19.91M | 21.49M | 11.75M |
Research & Development | 321.53M | 93.31M | 94.32M | 64.55M | 47.53M | 31.62M |
Other Expenses | n/a | n/a | -3.49M | n/a | n/a | n/a |
Operating Expenses | 371.64M | 121.19M | 122.54M | 84.46M | 69.02M | 43.37M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 371.64M | 121.19M | 126.04M | 93.42M | 69.02M | 43.37M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 9.87M | 3.44M | 3.36M | 1.98M | 1.86M | 1.86M |
Shares Outstanding (Diluted) | 9.87M | 3.44M | 3.36M | 1.98M | 1.86M | 1.86M |
EPS (Basic) | -70.50 | -34 | -35 | -46.60 | -37.80 | -26.60 |
EPS (Diluted) | -70.50 | -34 | -35 | -46.60 | -37.80 | -26.60 |
EBITDA | -693.09M | -113.39M | -114.37M | -83.13M | -67.47M | -42.76M |
EBIT | -695.98M | -116.91M | -117.86M | -92.09M | -68.9M | -43.37M |
Depreciation & Amortization | 2.89M | 3.53M | 3.49M | 8.96M | 1.43M | 605K |
Add to Watchlist
Select watchlists to add or remove VOR